STOCK TITAN

Biovie Inc SEC Filings

BIVIW NASDAQ

Welcome to our dedicated page for Biovie SEC filings (Ticker: BIVIW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Biovie's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Biovie's regulatory disclosures and financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report

FAQ

How many Biovie (BIVIW) SEC filings are available on StockTitan?

StockTitan tracks 2 SEC filings for Biovie (BIVIW), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Biovie (BIVIW)?

The most recent SEC filing for Biovie (BIVIW) was filed on May 11, 2026.